Physician profile
Alan S Slipak
NPI 1053739532
$9,661.81
in general payments reported to CMS, 2019-2025
25 companies · $1,205 in 2025
The $1,205 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.98 · 2020: $1,210 · 2021: $1,288 · 2022: $2,227 · 2023: $1,565 · 2024: $2,121 · 2025: $1,205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,891.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,264.20 | 2020-2025 | Mako, Triathlon, Insignia |
| Innovation Technologies INC | $1,613.40 | 2020-2024 | Irrisept |
| Depuy Synthes Sales INC. | $958.63 | 2021-2025 | Attune, Actis, Orthovisc |
| Zimmer Biomet Holdings, INC. | $381.01 | 2022-2025 | Persona |
| Smith+Nephew, INC. | $317.40 | 2022-2025 | Real Intelligence, Pico, "Acticoat 4"" X 4""" |
| Medtronic USA, INC. | $300.49 | 2020 | |
| Onkos Surgical, INC. | $287.05 | 2020-2022 | |
| Medtronic, INC. | $250.05 | 2021-2025 | Plasmablade(Tm), Aquamantys(Tm) |
| Bioventus LLC | $185.18 | 2022-2023 | Gelsyn-3 |
| Osteoremedies, LLC | $181.66 | 2022 | |
| Nuvasive Specialized Orthopedics, INC. | $152.18 | 2022 | |
| Uoc USA INC | $148.84 | 2021 | |
| Mid-Atlantic Surgical Systems, LLC | $131.58 | 2019-2024 | |
| Heron Therapeutics, INC. | $114.30 | 2024 | Zynrelef |
| Ferring Pharmaceuticals INC. | $74.32 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carbofix Orthopedics INC | $44.06 | 2020 | |
| Heraeus Medical, LLC. | $41.32 | 2024 | |
| Next Science LLC | $38.94 | 2022 | |
| Polynovo North America LLC | $38.11 | 2024 | Novosorb Btm |
| Medical Device Business Services, INC. | $37.64 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $34.18 | 2021-2024 | Iovera |
| Horizon Therapeutics Plc | $18.80 | 2022 | |
| Si-Bone, INC. | $16.44 | 2021 | |
| Ethicon US, LLC | $16.17 | 2024 | Surgicel Nu-Knit |
| Kci USA, INC. | $15.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Slipak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.